tirzepatide bimagrumab A drug called apitegromab may help to preserve lean body mass during weight loss with tirzepatide, a GLP-1 receptor agonist, according to a phase 2 clinical trial published in Nature Medicine. The Next Generation Antiobesity Medications: Setmelanotide,

adults reported taking a GLP-1 drug, with about 38% of those (about 2.3% total) taking the drug to address excess weight (Montero et al., 2024)

Finding the Root Cause Functional medicine goes beyond symptoms to uncover the root cause of illness

Insurance Support : Benefit from verified claims and handled prior authorizations

Anyone wishing to participate in a clinical trial of retatrutide should discuss this with their GP or specialist, or search for registered studies at clinicaltrials.gov or the MHRA Clinical Trials register

Greden, J

Management is primarily dietary, focusing on small, frequent meals and low-glycemic index foods to stabilize glucose levels